Latest filing published 11 Jan 2011 for HUMAN GENOME SCIENCES INC, €6,089.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jurgen Drews: trading record in brief
All filings by Jurgen Drews on record concern Human Genome Sciences Inc. Over a trading history stretching from 10 April 2009 to 10 January 2011, the count stands at 29 filings.
The open-market side counts 1 purchase for €23k alongside 10 sales for €2.1M. On balance, insiders were net sellers of €2.1M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 9 share grants and 9 option exercises.
The latest filing, published on 11 January 2011, reports a share grant of €6,089 in Human Genome Sciences Inc. The last purchase on record was published on 22 December 2009, which is 6,166 days ago. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jurgen Drews
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 304 shares@ US$25.83Common StockSEC:0001225208-11-002223:0
- 124 shares@ US$29.15Common StockSEC:0001225208-10-022930:0
- 252 shares@ US$25.23Common StockSEC:0001225208-10-017158:0
- 114 shares@ US$32.86Common StockSEC:0001225208-10-017158:1
- 20,732 shares@ US$10.69Common StockSEC:0001225208-10-016021:0
- 11,120 shares@ US$5.97Common StockSEC:0001225208-10-016021:1
- 5,782 shares@ US$2.09Common StockSEC:0001225208-10-016021:2
- 300 shares@ US$23.55Common StockSEC:0001225208-10-016021:3
- 5,782 shares@ US$23.34Common StockSEC:0001225208-10-016021:4
- 11,120 shares@ US$23.39Common StockSEC:0001225208-10-016021:5
- 20,432 shares@ US$23.18Common StockSEC:0001225208-10-016021:6
- 16,000 shares@ US$11.51Common StockSEC:0001225208-10-015855:0
- 14,900 shares@ US$11.33Common StockSEC:0001225208-10-015855:1
- 5,634 shares@ US$10.70Common StockSEC:0001225208-10-015855:2
- 1,100 shares@ US$11.33Common StockSEC:0001225208-10-015855:3
- 1,100 shares@ US$23.56Common StockSEC:0001225208-10-015855:4
- 5,634 shares@ US$24.08Common StockSEC:0001225208-10-015855:5
- 14,900 shares@ US$24.17Common StockSEC:0001225208-10-015855:6
- 16,000 shares@ US$23.59Common StockSEC:0001225208-10-015855:7
- 27,268 shares@ US$10.69Common StockSEC:0001225208-10-015855:8
- 10,366 shares@ US$10.70Common StockSEC:0001225208-10-015855:9
- 10,366 shares@ US$22.88Common StockSEC:0001225208-10-015855:10
- 27,268 shares@ US$22.80Common StockSEC:0001225208-10-015855:11
- 72 shares@ US$32.86Common StockSEC:0001225208-10-010241:0
- 162 shares@ US$30.82Common StockSEC:0001225208-10-001395:0
25 of 29 declarations
